Fulvestrant
NDC 70860-211, fulvestrant, injection, solution, from Athenex Pharmaceutical Division, LLC..
- Product NDC
- 70860-211
- Status
- Listed
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211422
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70860-211 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT50 mg/mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70860-211-74 | 70860021174 | 2 SYRINGE, GLASS in 1 CARTON (70860-211-74) / 5 mL in 1 SYRINGE, GLASS (70860-211-41) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8ed06e0e-c17b-4c71-8d03-888bcde4a638Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70860-211
Use it
Look up 70860-211 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70860-211 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70860-211. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.